Health

Results: 697-708 of 10116

Photocure Welcomes FDA Proposal to Initiate the Reclassification of Blue Light Cystoscopy Systems from Class III to Class II

Implantica presents the second quarter (Q2 2026) on August 21 at 15:00 CEST

NuCana Reports Second Quarter 2026 Financial Results and Provides Business Update

Laura Shannon joins Clinilabs as Chief Executive Officer as Gary Zammit, Ph.D., the Company’s founder, assumes the role of Executive Chairperson

Clinilabs Announces Leadership Expansion and Welcomes Laura Shannon as Chief Executive Officer and Promotion of Founder Gary Zammit, Ph.D., to Executive Chairperson

PR Newswire associated0

Innorna Nominated for 2026 Prix Galien USA Best Startup Award

PR Newswire associated0

Sciton Launches OMNI™ in Canada: A New Laser Hair Removal Platform Designed for All

PR Newswire associated0

Axtria to Build Industry's Largest Pharma-Specific AI Engineering Team, Scaling to 1,000 by December 2026

Newborn ICU admissions drop 50% in first full year of RSV maternal vaccine programme

Business Wire logo

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

PR Newswire associated0

Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA

Business Wire logo

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Andrés Vásquez Quintero, CEO & CTO of Azalea Vision

Azalea Vision Appoints Co-Founder Andrés Vasquez Quintero as Chief Executive Officer to Lead Next Phase of Clinical Development